Chairs
- Vicky Makker (New York City, United States of America)
- Alexandra Leary (Villejuif, France)
Introduction
Speakers
- Vicky Makker (New York City, United States of America)
Emerging molecular profiling models for advanced endometrial cancer: Prognosticators and predictors of benefit from IO and targeted therapeutics
Speakers
- Tjalling Bosse (Leiden, Netherlands)
The landscape of approved immune checkpoint inhibitors and TKI combinations in advanced endometrial cancer
Speakers
- Vicky Makker (New York City, United States of America)
Research insights: New immunotherapy combinations in clinical development for gynecological malignancies
Speakers
- Alexandra Leary (Villejuif, France)
Conclusions and wrap-up
Speakers
- Alexandra Leary (Villejuif, France)